TMO250110P630000
- 0.00
- 0.000.00%
Thermo Fisher Scientific Newsroom
Thermo Fisher Scientific's Olink Platform Selected for World's Largest Human Proteome Study
Ultima Genomics Announces UG 100 Sequencing Platform Selected for UK Biobank's Groundbreaking Human Proteome Study
Express News | Thermo Fisher Scientific’s Olink Platform Selected for World’s Largest Human Proteome Study
Growth Trends in the Pediatric Cancer Biomarkers Market, 2024-2034 - Roche, Thermo Fisher Scientific, Illumina, QIAGEN, and Bio-Rad Laboratories Dominate the Competition
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Human Embryonic Stem Cells Industry to Generate Revenues of $6.76 Billion by 2035, up From $2.26 Billion 2024 - Thermo Fisher Scientific, STEMCELL Technologies, and Astellas Pharma Dominate the Landscape
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Market Sells CES Tech News, ISM Tuesday as Nvidia Champions Robots Monday | Live Stock
We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today
CES Tech Conference Week Starts with Nvidia and Chips Climbing | Live Stock
Argus Adjusts Thermo Fisher Scientific's Price Target to $620 From $665
Thermo Fisher Scientific Hits 7-week High
Bernstein Maintains Thermo Fisher Scientific(TMO.US) With Hold Rating
Bernstein Sticks to Its Hold Rating for Thermo Fisher (TMO)
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Friday? More Like Grinch Day | Wall Street Today
Market Volatility Is Back. Here's How to Play It. -- Barrons.com
Santa Claus Came Without Rallying the Troops | Live Stock